These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 33225963)

  • 21. Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety.
    Litten RZ; Wilford BB; Falk DE; Ryan ML; Fertig JB
    Subst Abus; 2016; 37(2):286-98. PubMed ID: 26928397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ON-ICE trial: Investigation of the combined effects of oxytocin and naltrexone on stress-induced and alcohol cue-induced craving in alcohol use disorder-Study protocol of a phase II randomised double-blind placebo-controlled parallel-group trial.
    Zimmermann S; Thomas BC; Krisam J; Limprecht R; Klose C; Stenger M; Pourbaix M; Ries M; Vollstaedt-Klein S; Koopmann A; Lenz B; Kiefer F; Bach P
    BMJ Open; 2022 Apr; 12(4):e059672. PubMed ID: 35410938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial.
    Ray LA; Bujarski S; Shoptaw S; Roche DJ; Heinzerling K; Miotto K
    Neuropsychopharmacology; 2017 Aug; 42(9):1776-1788. PubMed ID: 28091532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Learning to resist the urge: a double-blind, randomized controlled trial investigating alcohol-specific inhibition training in abstinent patients with alcohol use disorder.
    Tschuemperlin RM; Stein M; Batschelet HM; Moggi F; Soravia LM
    Trials; 2019 Jul; 20(1):402. PubMed ID: 31277683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medication Development for Alcohol Use Disorder: A Focus on Clinical Studies.
    Leggio L; Falk DE; Ryan ML; Fertig J; Litten RZ
    Handb Exp Pharmacol; 2020; 258():443-462. PubMed ID: 31628604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder.
    Burnette EM; Nieto SJ; Grodin EN; Meredith LR; Hurley B; Miotto K; Gillis AJ; Ray LA
    Drugs; 2022 Feb; 82(3):251-274. PubMed ID: 35133639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Meta-Regression of Trial Features Predicting the Effects of Alcohol Use Disorder Pharmacotherapies on Drinking Outcomes in Randomized Clinical Trials: A Secondary Data Analysis.
    Grodin EN; Donato S; Du H; Green R; Bujarski S; Ray LA
    Alcohol Alcohol; 2022 Sep; 57(5):589-594. PubMed ID: 35229869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of varenicline on alcohol cue reactivity in heavy drinkers.
    Roberts W; Harrison ELR; McKee SA
    Psychopharmacology (Berl); 2017 Sep; 234(18):2737-2745. PubMed ID: 28600734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selecting an appropriate alcohol pharmacotherapy: review of recent findings.
    Castrén S; Mäkelä N; Alho H
    Curr Opin Psychiatry; 2019 Jul; 32(4):266-274. PubMed ID: 30973369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integration of pharmacotherapy for alcohol use disorder treatment in primary care settings: A scoping review.
    Hyland CJ; McDowell MJ; Bain PA; Huskamp HA; Busch AB
    J Subst Abuse Treat; 2023 Jan; 144():108919. PubMed ID: 36332528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topiramate versus naltrexone for alcohol use disorder: study protocol for a genotype-stratified, double-blind randomised controlled trial (TOP study).
    Morley KC; Kranzler HR; Luquin N; Baillie A; Shanahan M; Trent R; Teesson M; Haber PS
    Trials; 2018 Aug; 19(1):443. PubMed ID: 30115121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New approved and emerging pharmacological approaches to alcohol use disorder: a review of clinical studies.
    Morley KC; Perry CJ; Watt J; Hurzeler T; Leggio L; Lawrence AJ; Haber P
    Expert Opin Pharmacother; 2021 Jul; 22(10):1291-1303. PubMed ID: 33615945
    [No Abstract]   [Full Text] [Related]  

  • 33. Strategies to increase implementation of pharmacotherapy for alcohol use disorders: a structured review of care delivery and implementation interventions.
    Williams EC; Matson TE; Harris AHS
    Addict Sci Clin Pract; 2019 Feb; 14(1):6. PubMed ID: 30744686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Varenicline Combined With Medical Management on Alcohol Use Disorder With Comorbid Cigarette Smoking: A Randomized Clinical Trial.
    O'Malley SS; Zweben A; Fucito LM; Wu R; Piepmeier ME; Ockert DM; Bold KW; Petrakis I; Muvvala S; Jatlow P; Gueorguieva R
    JAMA Psychiatry; 2018 Feb; 75(2):129-138. PubMed ID: 29261824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in Pharmacotherapy Development: Human Clinical Studies.
    Litten RZ; Falk DE; Ryan ML; Fertig J; Leggio L
    Handb Exp Pharmacol; 2018; 248():579-613. PubMed ID: 29294197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An explorative single-arm clinical study to assess craving in patients with alcohol use disorder using Virtual Reality exposure (CRAVE)-study protocol.
    Lütt A; Tsamitros N; Wolbers T; Rosenthal A; Bröcker AL; Schöneck R; Bermpohl F; Heinz A; Beck A; Gutwinski S
    BMC Psychiatry; 2023 Nov; 23(1):839. PubMed ID: 37964300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of neuroimmune modulation on subjective response to alcohol in the natural environment.
    Meredith LR; Grodin EN; Montoya AK; Miranda R; Squeglia LM; Towns B; Evans C; Ray LA
    Alcohol Clin Exp Res; 2022 May; 46(5):876-890. PubMed ID: 35362101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Human Laboratory and Drug Development in Alcohol Use Disorder: Recent Updates.
    Chukwueke CC; Le Foll B
    Methods Mol Biol; 2019; 2011():195-219. PubMed ID: 31273701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naltrexone vs Placebo for the Treatment of Alcohol Dependence: A Randomized Clinical Trial.
    Oslin DW; Leong SH; Lynch KG; Berrettini W; O'Brien CP; Gordon AJ; Rukstalis M
    JAMA Psychiatry; 2015 May; 72(5):430-7. PubMed ID: 25760804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alcohol Use Disorder: The Role of Medication in Recovery.
    Mason BJ; Heyser CJ
    Alcohol Res; 2021; 41(1):07. PubMed ID: 34113531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.